The multiple complexes formed by the interaction of platelet factor 4 with heparin.
about
Histidine-rich glycoprotein inhibits the antiproliferative effect of heparin on smooth muscle cellsThe crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolutionRoles of platelet factor 4 in hematopoiesis and angiogenesisDrug-induced and drug-dependent immune thrombocytopenias.Determinants of PF4/heparin immunogenicityHeparin modifies the immunogenicity of positively charged proteins.Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia.Dynamic antibody-binding properties in the pathogenesis of HIT.Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.The antigenic complex in HIT binds to B-cells via complement and complement receptor 2 (CD21).Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketoneLow molecular weight heparin in acute coronary syndromes.Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombinModulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits.Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality?A model of the platelet factor 4 complex with heparin.Heparin and heparan sulfate bind to snake cardiotoxin. Sulfated oligosaccharides as a potential target for cardiotoxin action.Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4Binding of platelet factor 4 to heparin oligosaccharides.Heparin: new life for an old drug.Specific thrombin inhibitors in vivo.An explanation of the asthma paradox.Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.
P2860
Q24682837-7530B5C6-8CBA-4125-8049-AD61BD8F863DQ27729945-96AF2B05-DDCD-4920-AEDE-A1E7C9A7A619Q28294538-C25A6D66-C6E0-4CC8-B1F7-71EF4B1E501BQ33339739-CDAADABC-1B43-4819-ACD5-8FC54D489810Q33376629-1BBBEE9B-2170-4E68-AB53-B5BA42944579Q33391937-E3AB712B-08D6-45BD-B9BE-F58EA018C5BCQ33400431-0C2D824F-D32A-401F-AE2B-A963EDEBC14AQ33401163-42AF3FB0-B967-4B87-BD79-AA3D6DE0DF76Q33403225-F5DF6D43-4E69-4848-8C44-8B9437EB455DQ33406904-526BC639-2576-48ED-8B9B-E7247964A054Q33433868-85E8EFE6-A7B3-4A23-B114-09AA57A72DDEQ33502479-2D9E9711-23FA-4317-B44A-A6C23F4ABB75Q33571477-09FD111E-2A09-4AE8-BE2C-6CCE5EDA7080Q34027303-08A9AA8F-56F8-401A-B661-68B55531D9DEQ34308795-6FD9BE71-AF8D-4E9A-AD73-3364EB0C653FQ34452632-E5EB9BBC-B535-4D49-87E2-6CA91976E61DQ34530666-6F37F883-6143-4E70-B57A-8C3E59B509D8Q34691706-E63B30D7-6F8E-45CE-8D8D-569254F0DF46Q36330416-220D34B9-6310-4F38-B682-AE40AEA197E0Q38175433-CC96C22D-24A2-4908-9297-190942AA885DQ38325515-93A26D1D-7BEC-4FF3-9C08-C0D7D8AF8A59Q38349247-80D16512-AA3D-4E99-883F-FFFE87484D5DQ38353921-48B4FFD9-2958-4504-B013-A6CCC201E3B4Q38354910-52107AE8-8B15-4954-87FE-A6D23430058BQ40164066-247BA6A1-E50A-4B58-9FBE-7837E3120B4BQ40664734-F0298871-7536-4C96-ABC6-46A0F8B6EAB3Q40710023-93D2D5A9-9B6B-49B4-9077-9B6C2E7C48D6Q41086292-67D4F2D5-A039-486E-A06B-39F85E56AD76Q42002922-BE1A8AC5-1757-4291-8882-9E393FB7CE47
P2860
The multiple complexes formed by the interaction of platelet factor 4 with heparin.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
The multiple complexes formed by the interaction of platelet factor 4 with heparin.
@en
The multiple complexes formed by the interaction of platelet factor 4 with heparin.
@nl
type
label
The multiple complexes formed by the interaction of platelet factor 4 with heparin.
@en
The multiple complexes formed by the interaction of platelet factor 4 with heparin.
@nl
prefLabel
The multiple complexes formed by the interaction of platelet factor 4 with heparin.
@en
The multiple complexes formed by the interaction of platelet factor 4 with heparin.
@nl
P2093
P2860
P356
P1433
P1476
The multiple complexes formed by the interaction of platelet factor 4 with heparin.
@en
P2093
D S Pepper
J J Holbrook
M Luscombe
S E Marshall
P2860
P304
P356
10.1042/BJ1910769
P407
P577
1980-12-01T00:00:00Z